vs
Aveanna Healthcare Holdings, Inc.（AVAH）与LG化学（CHE）财务数据对比。点击上方公司名可切换其他公司
Aveanna Healthcare Holdings, Inc.的季度营收约是LG化学的1.5倍（$621.9M vs $420.0M）。LG化学净利率更高（15.8% vs 2.3%，领先13.5%）。Aveanna Healthcare Holdings, Inc.同比增速更快（22.2% vs 3.1%）。过去两年Aveanna Healthcare Holdings, Inc.的营收复合增速更高（14.0% vs 5.9%）
Aveanna Healthcare Holdings, Inc.是美国领先的家庭及社区医疗服务提供商，核心业务覆盖儿科家庭护理、成人个人照护、临终关怀、输液治疗等领域，通过覆盖全美的本地护理中心网络为各地患者提供服务，服务对象涵盖公共及私人付费群体。
LG化学是韩国最大的化工企业，总部位于韩国首尔，2021年按销售额统计为全球第九大化工企业。其前身为生产化妆品的乐喜化学工业株式会社，目前已全面转型为仅面向企业客户的B2B经营模式。
AVAH vs CHE — 直观对比
营收规模更大
AVAH
是对方的1.5倍
$420.0M
营收增速更快
AVAH
高出19.1%
3.1%
净利率更高
CHE
高出13.5%
2.3%
两年增速更快
AVAH
近两年复合增速
5.9%
损益表 — Q3 2026 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $621.9M | $420.0M |
| 净利润 | $14.1M | $66.3M |
| 毛利率 | 32.6% | — |
| 营业利润率 | 8.6% | 20.1% |
| 净利率 | 2.3% | 15.8% |
| 营收同比 | 22.2% | 3.1% |
| 净利润同比 | 132.8% | -7.6% |
| 每股收益（稀释后） | $0.06 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVAHCHE
| Q1 26 | — | $420.0M | ||
| Q4 25 | — | $639.3M | ||
| Q3 25 | $621.9M | $624.9M | ||
| Q2 25 | $589.6M | $618.8M | ||
| Q1 25 | $559.2M | $646.9M | ||
| Q4 24 | $519.9M | $411.0M | ||
| Q3 24 | $509.0M | $391.4M | ||
| Q2 24 | $505.0M | $374.6M |
净利润AVAHCHE
| Q1 26 | — | $66.3M | ||
| Q4 25 | — | $76.8M | ||
| Q3 25 | $14.1M | $64.2M | ||
| Q2 25 | $27.0M | $52.5M | ||
| Q1 25 | $5.2M | $71.8M | ||
| Q4 24 | $29.2M | $90.3M | ||
| Q3 24 | $-42.8M | $75.8M | ||
| Q2 24 | $13.9M | $70.9M |
毛利率AVAHCHE
| Q1 26 | — | — | ||
| Q4 25 | — | 35.2% | ||
| Q3 25 | 32.6% | 31.5% | ||
| Q2 25 | 35.8% | 29.8% | ||
| Q1 25 | 32.8% | 33.5% | ||
| Q4 24 | 33.0% | 1.2% | ||
| Q3 24 | 31.4% | -1.2% | ||
| Q2 24 | 31.3% | -4.1% |
营业利润率AVAHCHE
| Q1 26 | — | 20.1% | ||
| Q4 25 | — | 15.7% | ||
| Q3 25 | 8.6% | 12.0% | ||
| Q2 25 | 13.6% | 11.0% | ||
| Q1 25 | 9.3% | 14.6% | ||
| Q4 24 | 8.8% | 27.7% | ||
| Q3 24 | 6.7% | 23.5% | ||
| Q2 24 | 7.4% | 23.5% |
净利率AVAHCHE
| Q1 26 | — | 15.8% | ||
| Q4 25 | — | 12.0% | ||
| Q3 25 | 2.3% | 10.3% | ||
| Q2 25 | 4.6% | 8.5% | ||
| Q1 25 | 0.9% | 11.1% | ||
| Q4 24 | 5.6% | 22.0% | ||
| Q3 24 | -8.4% | 19.4% | ||
| Q2 24 | 2.8% | 18.9% |
每股收益（稀释后）AVAHCHE
| Q1 26 | — | — | ||
| Q4 25 | — | $5.45 | ||
| Q3 25 | $0.06 | $4.46 | ||
| Q2 25 | $0.13 | $3.57 | ||
| Q1 25 | $0.03 | $4.86 | ||
| Q4 24 | $0.15 | $6.00 | ||
| Q3 24 | $-0.22 | $5.00 | ||
| Q2 24 | $0.07 | $4.65 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.9M | $16.9M |
| 总债务越低越好 | $1.3B | $91.2M |
| 股东权益账面价值 | $9.2M | $848.0M |
| 总资产 | $1.8B | $1.5B |
| 负债/权益比越低杠杆越低 | 141.83× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资AVAHCHE
| Q1 26 | — | $16.9M | ||
| Q4 25 | — | $74.5M | ||
| Q3 25 | $145.9M | $129.8M | ||
| Q2 25 | $100.7M | $249.9M | ||
| Q1 25 | $71.5M | $173.9M | ||
| Q4 24 | $84.3M | $178.3M | ||
| Q3 24 | $78.5M | $238.5M | ||
| Q2 24 | $47.7M | $222.9M |
总债务AVAHCHE
| Q1 26 | — | $91.2M | ||
| Q4 25 | — | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — |
股东权益AVAHCHE
| Q1 26 | — | $848.0M | ||
| Q4 25 | — | $979.4M | ||
| Q3 25 | $9.2M | $1.1B | ||
| Q2 25 | $-12.0M | $1.2B | ||
| Q1 25 | $-100.1M | $1.2B | ||
| Q4 24 | $-123.6M | $1.1B | ||
| Q3 24 | $-156.4M | $1.2B | ||
| Q2 24 | $-119.0M | $1.2B |
总资产AVAHCHE
| Q1 26 | — | $1.5B | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | $1.8B | $1.6B | ||
| Q2 25 | $1.8B | $1.7B | ||
| Q1 25 | $1.7B | $1.7B | ||
| Q4 24 | $1.7B | $1.7B | ||
| Q3 24 | $1.6B | $1.8B | ||
| Q2 24 | $1.7B | $1.7B |
负债/权益比AVAHCHE
| Q1 26 | — | 0.11× | ||
| Q4 25 | — | — | ||
| Q3 25 | 141.83× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.2M | $88.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | 2.36× | 1.33× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AVAHCHE
| Q1 26 | — | $88.2M | ||
| Q4 25 | — | $133.5M | ||
| Q3 25 | $33.2M | $83.4M | ||
| Q2 25 | $51.6M | $138.6M | ||
| Q1 25 | $-8.6M | $32.7M | ||
| Q4 24 | $13.4M | $164.9M | ||
| Q3 24 | $29.4M | $90.5M | ||
| Q2 24 | $1.8M | $77.5M |
自由现金流AVAHCHE
| Q1 26 | — | — | ||
| Q4 25 | — | $117.2M | ||
| Q3 25 | — | $66.0M | ||
| Q2 25 | — | $122.8M | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | — | $152.2M | ||
| Q3 24 | — | $77.0M | ||
| Q2 24 | — | $66.5M |
自由现金流率AVAHCHE
| Q1 26 | — | — | ||
| Q4 25 | — | 18.3% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | — | 19.8% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 37.0% | ||
| Q3 24 | — | 19.7% | ||
| Q2 24 | — | 17.7% |
资本支出强度AVAHCHE
| Q1 26 | — | 4.1% | ||
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | — | 3.5% | ||
| Q2 24 | — | 3.0% |
现金转化率AVAHCHE
| Q1 26 | — | 1.33× | ||
| Q4 25 | — | 1.74× | ||
| Q3 25 | 2.36× | 1.30× | ||
| Q2 25 | 1.91× | 2.64× | ||
| Q1 25 | -1.66× | 0.46× | ||
| Q4 24 | 0.46× | 1.83× | ||
| Q3 24 | — | 1.19× | ||
| Q2 24 | 0.13× | 1.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVAH
| Private Duty Services | $514.4M | 83% |
| Home Health And Hospice | $62.4M | 10% |
| Medical Solutions | $45.1M | 7% |
CHE
| Homecare | $371.1M | 88% |
| Inpatient | $35.9M | 9% |
| Other | $13.0M | 3% |
